NO20053997L - Oligosaccharidderivat - Google Patents

Oligosaccharidderivat

Info

Publication number
NO20053997L
NO20053997L NO20053997A NO20053997A NO20053997L NO 20053997 L NO20053997 L NO 20053997L NO 20053997 A NO20053997 A NO 20053997A NO 20053997 A NO20053997 A NO 20053997A NO 20053997 L NO20053997 L NO 20053997L
Authority
NO
Norway
Prior art keywords
groups
pharmacologically acceptable
group
oligosaccharidderivat
chem
Prior art date
Application number
NO20053997A
Other languages
English (en)
Other versions
NO20053997D0 (no
Inventor
Takeshi Honda
Akira Okuno
Masanori Lzumi
Xiaoliu Li
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO20053997D0 publication Critical patent/NO20053997D0/no
Publication of NO20053997L publication Critical patent/NO20053997L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)

Abstract

Forbindelse med en struktur representert ved den påfølgende generelle formel (I): A er en syklisk gruppe osv. ; R1 og R2 er begge alkyl, hydroksymetyl osv.; og n er 1 eller 2; eller et farmakologisk aksepterbart salt eller en ester av forbindelsen. Forbindelsene er svært aktive og sikre og er anvendbare som terapeutiske midler og/eller forebyggende midler for diabetes osv.
NO20053997A 2003-01-30 2005-08-29 Oligosaccharidderivat NO20053997L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003022800 2003-01-30
PCT/JP2004/000879 WO2004067542A1 (ja) 2003-01-30 2004-01-29 オリゴ糖誘導体

Publications (2)

Publication Number Publication Date
NO20053997D0 NO20053997D0 (no) 2005-08-29
NO20053997L true NO20053997L (no) 2005-10-28

Family

ID=32820702

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053997A NO20053997L (no) 2003-01-30 2005-08-29 Oligosaccharidderivat

Country Status (21)

Country Link
US (2) US7361744B2 (no)
EP (1) EP1589023B1 (no)
KR (1) KR101050981B1 (no)
CN (2) CN101367851A (no)
AT (1) ATE478884T1 (no)
AU (1) AU2004207726B2 (no)
BR (1) BRPI0406990A (no)
CA (1) CA2514931A1 (no)
DE (1) DE602004028799D1 (no)
DK (1) DK1589023T3 (no)
ES (1) ES2349736T3 (no)
IL (1) IL169577A (no)
MX (1) MXPA05008190A (no)
NO (1) NO20053997L (no)
NZ (1) NZ541455A (no)
PL (1) PL377462A1 (no)
PT (1) PT1589023E (no)
RU (1) RU2290408C2 (no)
TW (1) TWI318202B (no)
WO (1) WO2004067542A1 (no)
ZA (1) ZA200506075B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200612968A (en) * 2004-07-29 2006-05-01 Sankyo Co Oligosaccharide derivatives containing with heterocycle
TW200608967A (en) 2004-07-29 2006-03-16 Sankyo Co Pharmaceutical compositions containing with diabetic agent
TW200735880A (en) * 2006-01-27 2007-10-01 Sankyo Co Medicinal compositions for preventing or treating heart failure
GB0614947D0 (en) * 2006-07-27 2006-09-06 Isis Innovation Epitope reduction therapy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3785895D1 (de) * 1986-08-13 1993-06-24 Hoechst Ag Oxiran-pseudooligosaccharide, verfahren zu deren herstellung, deren verwendung und pharmazeutische praeparate.
US5318986A (en) * 1989-10-19 1994-06-07 Mitsui Norin Co., Ltd. Method of inhibiting the activity of α-amylase
US5783568A (en) * 1994-06-10 1998-07-21 Sugen, Inc. Methods for treating cancer and other cell proliferative diseases
FR2751334B1 (fr) * 1996-07-19 1998-10-16 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
JP4643775B2 (ja) * 1999-01-13 2011-03-02 日本食品化工株式会社 香気成分生成阻害剤
JP3909735B2 (ja) * 1999-02-22 2007-04-25 キッコーマン株式会社 マルトオリゴ糖誘導体及びその用途
WO2000050494A1 (en) 1999-02-23 2000-08-31 Ips Corporation Low voc (volatile organic compounds), dimethyl-2-piperidone solvent-based, pvc and cpvc pipe and component adhesives and primers containing minimal or no tetrahydrofuran
JP4373671B2 (ja) 2000-06-06 2009-11-25 キッコーマン株式会社 マルトオリゴ糖誘導体及びその用途

Also Published As

Publication number Publication date
AU2004207726A1 (en) 2004-08-12
EP1589023B1 (en) 2010-08-25
ZA200506075B (en) 2006-05-31
KR101050981B1 (ko) 2011-07-21
RU2290408C2 (ru) 2006-12-27
TW200502204A (en) 2005-01-16
PL377462A1 (pl) 2006-02-06
RU2005124286A (ru) 2006-01-27
CN1768073A (zh) 2006-05-03
AU2004207726B2 (en) 2007-03-15
BRPI0406990A (pt) 2006-01-10
US20060025350A1 (en) 2006-02-02
DK1589023T3 (da) 2010-12-13
US20080194495A1 (en) 2008-08-14
US7361744B2 (en) 2008-04-22
ES2349736T3 (es) 2011-01-11
IL169577A0 (en) 2007-07-04
IL169577A (en) 2010-06-16
EP1589023A4 (en) 2008-12-10
HK1077070A1 (en) 2006-02-03
CN101367851A (zh) 2009-02-18
EP1589023A1 (en) 2005-10-26
CA2514931A1 (en) 2004-08-12
WO2004067542A1 (ja) 2004-08-12
NO20053997D0 (no) 2005-08-29
KR20050094465A (ko) 2005-09-27
MXPA05008190A (es) 2006-02-17
NZ541455A (en) 2007-08-31
US7632930B2 (en) 2009-12-15
ATE478884T1 (de) 2010-09-15
TWI318202B (en) 2009-12-11
PT1589023E (pt) 2010-10-29
DE602004028799D1 (en) 2010-10-07
CN100360548C (zh) 2008-01-09

Similar Documents

Publication Publication Date Title
ATE372767T1 (de) Dpp-iv-hemmer
UA89788C2 (ru) Композиция и способ борьбы с насекомыми или клещами, пиперидиновые производные
DK1814846T3 (da) 11beta-HSD1-inhibitorer
DE60330407D1 (de) Synthese von Epothilonen, Zwischenprodukte davon, Analoga und ihre Verwendung
EP1642880A4 (en) PROTEIN INHIBITORS OF THE HSP90 FAMILY
ATE358484T1 (de) Antidiabetische medikamente
NO20053762L (no) Kondensert furanforbindelse.
CY1111271T1 (el) Παραγωγο τριαζολονης
NO20052074L (no) Substituerte benzoksazinoner og anvendelser derav.
EP1634874A4 (en) imidazolidine
ATE503746T1 (de) Neue imidazolidinderivate
NO20052908D0 (no) Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
ATE487685T1 (de) (-)-stereoisomer von 2,6-di-sec-butylphenol und analoga davon
EA200700997A1 (ru) 2,5- и 2,6-дизамещенные аналоги бензазола, полезные в качестве ингибиторов протеинкиназ
BR0200536A (pt) Compostos de sulfonilpiridazinana úteis como inibidores de aldose reductase
NO20053997D0 (no) Oligosaccharidderivat
EP2045258A4 (en) 3y-ETHYNYLCYTIDINDERIVAT
ATE244258T1 (de) Halo-derivate von 9-deoxo-9a-aza-9a- homerythromycin a
BRPI0416982B1 (pt) Derivados da indolina espirocondensados, processo para combater e controlar insetos, acarinos, nematóides ou moluscos, e composição inseticida, acaricida e nematicida
DE60213541D1 (de) Discodermolid-Analoga und ihre pharmazeutische Verwendung
DE60238847D1 (de) Pyrimidinderivate enthaltendes medikament
MX2008002753A (es) Derivados de piridazinona utilizados para el tratamiento de dolor.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application